Sanofi Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
6,175.00
6,698.00
6,251.00
10,422.00
7,798.00
13,778.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
1,795.00
-615.00
413.00
-707.00
1,409.00
-325.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
10,750.00
9,081.00
10,258.00
10,526.00
10,522.00
7,418.00
Cash Flow from Investing Activities
-2,447.00
-4,407.00
-6,203.00
-2,075.00
-7,298.00
3,619.00
Cash Flow from Financing Activities
-8,207.00
-5,763.00
-8,049.00
-5,821.00
-7,056.00
-6,485.00
Net Cash Inflow / Outflow
49.00
-1,102.00
-4,026.00
2,638.00
-3,817.00
4,488.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-47.00
-13.00
-32.00
8.00
15.00
-64.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in EUR Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Sanofi
Figures in Million
consolidated Cash Flow Results
Change(EUR)
Change(%)
Profit Before Tax
6175
578.8
5,597.00
966.86%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
1795
0.3
1,795.00
598233.33%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
10750
1138.4
9,612.00
844.31%
Cash Flow from Investing Activities
-2447
-615.2
-1,832.00
-297.76%
Cash Flow from Financing Activities
-8207
298.4
-8,505.00
-2850.34%
Net Cash Inflow / Outflow
49
825.8
-776.00
-94.07%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-47
4.2
-51.00
-1219.05%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 18.38% vs -11.47% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
10,750.00
9,081.00
18.38%






